4.6 Article

Mutanobactin A from the human oral pathogen Streptococcus mutans is a cross-kingdom regulator of the yeast-mycelium transition

Journal

ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 8, Issue 24, Pages 5486-5489

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c0ob00579g

Keywords

-

Funding

  1. National Institutes of Health [1R01AI085161-01]
  2. University of Oklahoma College of Arts and Sciences
  3. Department of Chemistry and Biochemistry
  4. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085161] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018893] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092219] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The recent investigation of a gene cluster encoding for a hybrid PKS-NRPS metabolite in the oral pathogen Streptococcus mutans UA159 yielded evidence that this natural product might play an important role regulating a range of stress tolerance factors. We have now characterized the major compound generated from this gene cluster, mutanobactin A, and demonstrated that this secondary metabolite is also capable of influencing the yeast-mycelium transition of Candida albicans.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available